{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:46:32Z","timestamp":1785509192129,"version":"3.56.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/med.0b013e328338f608","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T06:44:43Z","timestamp":1294987483000},"page":"217-223","source":"Crossref","is-referenced-by-count":118,"title":["Adrenal insufficiency: etiology, diagnosis and treatment"],"prefix":"10.1097","volume":"17","author":[{"given":"Nicola","family":"Neary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynnette","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20211004","article-title":"On the constitutional and local effects of disease of the supra-renal capsules","author":"Addison","year":"1855"},{"key":"R2-8-20211004","first-page":"1762","article-title":"Is the prevalence of Addison's disease underestimated?","volume":"84","author":"Laureti","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-8-20211004","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/pgmj.73.859.286","article-title":"The prevalence of Addison's disease in Coventry, UK","volume":"73","author":"Willis","year":"1997","journal-title":"Postgrad Med J"},{"key":"R4-8-20211004","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(05)66736-0","article-title":"Congenital adrenal hyperplasia","volume":"365","author":"Merke","year":"2005","journal-title":"Lancet"},{"key":"R5-8-20211004","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/361726a0","article-title":"Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters","volume":"361","author":"Mosser","year":"1993","journal-title":"Nature"},{"key":"R6-8-20211004","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/jc.2006-1873","article-title":"Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene","volume":"92","author":"Wolff","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-8-20211004","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1210\/jc.2009-1368","article-title":"Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry","volume":"94","author":"Erichsen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-8-20211004","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1210\/jc.2009-1308","article-title":"Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes","volume":"94","author":"Triolo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-8-20211004","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.molimm.2007.01.032","article-title":"MICA marks additional risk factors for type 1 diabetes on extended HLA haplotypes: an association and meta-analysis","volume":"44","author":"Alizadeh","year":"2007","journal-title":"Mol Immunol"},{"key":"R10-8-20211004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1749-6632.2002.tb02993.x","article-title":"MHC class I chain-related gene alleles 5 and 5.1 are transmitted more frequently to type 1 diabetes offspring in HBDI families","volume":"958","author":"Zake","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"R11-8-20211004","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1056\/NEJMra0804635","article-title":"Predisposing factors for adrenal insufficiency","volume":"360","author":"Bornstein","year":"2009","journal-title":"N Engl J Med"},{"key":"R12-8-20211004","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(09)60949-1","article-title":"Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial","volume":"374","author":"Jabre","year":"2009","journal-title":"Lancet"},{"key":"R13-8-20211004","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1634\/theoncologist.12-1-107","article-title":"Food and Drug Administration drug approval summary: sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma","volume":"12","author":"Rock","year":"2007","journal-title":"Oncologist"},{"key":"R14-8-20211004","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinte.1971.00310230091007","article-title":"Screening for adrenocortical insufficiency with cosyntropin (synthetic ACTH)","volume":"128","author":"Speckart","year":"1971","journal-title":"Arch Intern Med"},{"key":"R15-8-20211004","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-139-3-200308050-00009","article-title":"Diagnosis of adrenal insufficiency","volume":"139","author":"Dorin","year":"2003","journal-title":"Ann Intern Med"},{"key":"R16-8-20211004","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1210\/jc.2008-0710","article-title":"Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: a metaanalysis","volume":"93","author":"Kazlauskaite","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-8-20211004","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ncpendmet1038","article-title":"The low-dose corticotropin-stimulation test revisited: the less, the better?","volume":"5","author":"Stewart","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"R18-8-20211004","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1515\/JPEM.2008.21.12.1129","article-title":"Reliability of the low dose synacthen test in children undergoing pituitary function testing","volume":"21","author":"Mushtaq","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R19-8-20211004","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2265.1999.00773.x","article-title":"Reproducibility of the cortisol response to stimulation with the low dose (1 microg) of ACTH","volume":"51","author":"Park","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R20-8-20211004","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EJE-09-0746","article-title":"Technical details influence the diagnostic accuracy of the 1 microg ACTH stimulation test","volume":"162","author":"Wade","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"R21-8-20211004","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/jc.2005-1131","article-title":"The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis","volume":"91","author":"Agha","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-8-20211004","first-page":"49","article-title":"The apparent free cortisol concentration and the free cortisol index: a comparative study","volume":"25","author":"Brien","year":"1981","journal-title":"J Nucl Med Allied Sci"},{"key":"R23-8-20211004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-08-0600","article-title":"Diagnosis of secondary adrenal insufficiency in patients with hypothalamic-pituitary disease: comparison between serum and salivary cortisol during the high-dose short synacthen test","volume":"160","author":"Deutschbein","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R24-8-20211004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry","volume":"72","author":"Esteban","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-8-20211004","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison's disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-8-20211004","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"R27-8-20211004","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1530\/EJE-08-0880","article-title":"Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone","volume":"160","author":"Lovas","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R28-8-20211004","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2007-1134","article-title":"Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial","volume":"93","author":"Gurnell","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-8-20211004","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1210\/jc.2007-0685","article-title":"Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis","volume":"92","author":"Hahner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-8-20211004","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1210\/jcem-33-1-14","article-title":"Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects","volume":"33","author":"Weitzman","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-8-20211004","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1530\/EJE-08-0578","article-title":"Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens","volume":"159","author":"Bleicken","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"R33-8-20211004","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EJE-07-0052","article-title":"Continuous subcutaneous hydrocortisone infusion in Addison's disease","volume":"157","author":"Lovas","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"R34-8-20211004","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10484-009-9082-5","article-title":"Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study","volume":"34","author":"Harbeck","year":"2009","journal-title":"Appl Psychophysiol Biofeedback"},{"key":"R35-8-20211004","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1517\/17425255.4.6.749","article-title":"Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors","volume":"4","author":"Lennernas","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R37-8-20211004","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJM199909303411401","article-title":"Dehydroepiandrosterone replacement in women with adrenal insufficiency","volume":"341","author":"Arlt","year":"1999","journal-title":"N Engl J Med"},{"key":"R38-8-20211004","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1210\/jc.2002-020769","article-title":"Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial","volume":"88","author":"Lovas","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-8-20211004","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1210\/jcem-59-3-551","article-title":"Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood","volume":"59","author":"Orentreich","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-8-20211004","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1210\/jcem.83.6.4850","article-title":"Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression","volume":"83","author":"Arlt","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R41-8-20211004","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1210\/jc.2009-0672","article-title":"A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency","volume":"94","author":"Alkatib","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R42-8-20211004","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2008-1982","article-title":"Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial","volume":"94","author":"Binder","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-8-20211004","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1210\/jc.2002-021603","article-title":"Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men","volume":"88","author":"Kawano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R44-8-20211004","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1210\/jc.2003-031560","article-title":"Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors","volume":"89","author":"Williams","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R45-8-20211004","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1210\/jc.2008-2636","article-title":"Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial","volume":"94","author":"Rice","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-8-20211004","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.09.060","article-title":"High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies","volume":"51","author":"van der Steeg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R47-8-20211004","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM199809033391012","article-title":"Lovastatin for X-linked adrenoleukodystrophy","volume":"339","author":"Singh","year":"1998","journal-title":"N Engl J Med"},{"key":"R48-8-20211004","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/1531-8249(200004)47:4<552::AID-ANA28>3.0.CO;2-0","article-title":"Simvastatin and plasma very-long-chain fatty acids in X-linked adrenoleukodystrophy","volume":"47","author":"Verrips","year":"2000","journal-title":"Ann Neurol"},{"key":"R49-8-20211004","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1056\/NEJMc0907735","article-title":"Lovastatin in X-linked adrenoleukodystrophy","volume":"362","author":"Engelen","year":"2010","journal-title":"N Engl J Med"},{"key":"R51-8-20211004","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI103772","article-title":"Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection","volume":"37","author":"Melby","year":"1958","journal-title":"J Clin Invest"},{"key":"R52-8-20211004","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MED.0b013e3283307d53","article-title":"Relative adrenal insufficiency","volume":"16","author":"Loriaux","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R53-8-20211004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00000658-197609000-00011","article-title":"Steroids in the treatment of clinical septic shock","volume":"184","author":"Schumer","year":"1976","journal-title":"Ann Surg"},{"key":"R54-8-20211004","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM198411013111801","article-title":"The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study","volume":"311","author":"Sprung","year":"1984","journal-title":"N Engl J Med"},{"key":"R55-8-20211004","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"J Am Med Assoc"},{"key":"R56-8-20211004","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jama.283.8.1038","article-title":"A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin","volume":"283","author":"Annane","year":"2000","journal-title":"J Am Med Assoc"},{"key":"R57-8-20211004","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMoa020266","article-title":"Measurements of serum free cortisol in critically ill patients","volume":"350","author":"Hamrahian","year":"2004","journal-title":"N Engl J Med"},{"key":"R58-8-20211004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"R59-8-20211004","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2125.1998.00833.x","article-title":"Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve","volume":"46","author":"Annane","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"R60-8-20211004","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","article-title":"Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine","volume":"36","author":"Marik","year":"2008","journal-title":"Crit Care Med"},{"key":"R61-8-20211004","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1213\/ane.0b013e318172fdba","article-title":"Free cortisol in sepsis and septic shock","volume":"106","author":"Bendel","year":"2008","journal-title":"Anesth Analg"}],"container-title":["Current Opinion in Endocrinology, Diabetes &amp; Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201006000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T01:05:29Z","timestamp":1633309529000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201006000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e328338f608","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}